Ormsby Eleanor L, Pavlik Edward J, McGahan John P
Department of Radiology, University of California Davis Medical Center, 4860 Y Street, Suite 3100, Sacramento, CA 95817, USA.
Department of Radiology, Kaiser Permanente Sacramento, 2025 Morse Ave, CA 95825, USA.
Diagnostics (Basel). 2017 Apr 28;7(2):25. doi: 10.3390/diagnostics7020025.
Women that are positive for an ovarian abnormality in a clinical setting can have either a malignancy or a benign tumor with probability favoring the benign alternative. Accelerating the abnormality to surgery will result in a high number of unnecessary procedures that will place cost burdens on the individual and the health delivery system. Surveillance using serial ultrasonography is a reasonable alternative that can be used to discover if changes in the ovarian abnormality will occur that favor either a malignant or benign interpretation. Several ovarian cancer screening trials have had extensive experiences with changes in subclinical ovarian abnormalities in normal women that can define growth, stability or resolution and give some idea of the time frame over which changes occur. The present report examines these experiences and relates them to the current understanding of ovarian cancer ontology, presenting arguments related to the benefits of surveillance.
在临床环境中卵巢异常检测呈阳性的女性，其卵巢肿物可能是恶性肿瘤，也可能是良性肿瘤，且更有可能是良性的。将异常情况迅速推进至手术会导致大量不必要的手术操作，给个人和医疗系统带来成本负担。采用连续超声检查进行监测是一种合理的替代方法，可用于发现卵巢异常情况是否会出现有利于恶性或良性判断的变化。多项卵巢癌筛查试验在正常女性亚临床卵巢异常变化方面积累了丰富经验，这些变化可明确肿物的生长、稳定或消退情况，并能大致了解变化发生的时间框架。本报告审视了这些经验，并将其与当前对卵巢癌本体论的理解相关联，提出了有关监测益处的观点。
